Scientists at NYU have created a drug that targets cancer-causing HER2 mutations without harming healthy cells. This new ...

Antibodies show promise as candidates for therapeutics as well as tools for advancing mechanistic studies of the HER family receptors.

A previvor is essentially someone who has a genetic predisposition to certain cancers, but who may or may not currently have ...

For some proteins, a single mutation, or change in its DNA instructions, is all it takes to tip the balance between functioning normally and causing cancer. But despite causing major disease, these ...

An immune protein could hold the key to developing new drugs to help fight bowel cancer, according to new research from The ...

The past decade has witnessed a rapid expansion of genetic tests, including new instruments to inform patients who have been ...

Researchers have mapped the genetic landscape of cancer drug resistance, uncovering that DNA changes can be grouped into four main categories and highlighting possible new therapeutic targets.

Breast cancer is rapidly increasing among Indian women, with genetic factors like BRCA1 and BRCA2 mutations playing a crucial ...

Researchers obtain detailed picture of the specific mechanisms by which each individual mutation studied impacts drug response.

Wolpin’s team used AI to find patterns in over nine million patients, looking at medical records, family history and genetic ...

Scientists discovered the cancer-causing cell with a genetic mutation that causes a common variant of breast cancer first emerges in patients around the age of puberty. A team of researchers ...

Breast cancer in men can be misdiagnosed or overlooked because it’s so rare, but early detection can be lifesaving.